BioNexus Gene Lab Corp's total assets for Q3 2024 were $11.00M, a decrease of -1.30% from the previous quarter. BGLC total liabilities were $1.61M for the fiscal quarter, a 0.81% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.